ASP-2408

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameASP-2408
Drug Alias NameASP2408ASP 2408ASP-2408
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionCluster of differentiation 86 inhibitorsCluster of differentiation 80 inhibitors
TargetsCluster of differentiation 80Cluster of differentiation 86
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMaxygen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncAstellas Pharma Global Development Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A